We've seen this happen time and again
Understanding the FDA's Compounding Category System For non-clinical readers, the three-tier classification is worth spelling out plainly: Category 1 substances can be legally compounded by licensed 503A pharmacies (individual prescription-based) and 503B outsourcing facilities (larger-scale production)
Mechanistically, NNMT suppression increased adipose SAM and NAD, upregulated polyamine flux enzymes (ODC, SSAT), and altered histone methylation consistent with a shift toward oxidative metabolism [2]
Although research remains at the preclinical animal stage, the product has become an important tool for dissecting glucose metabolism disorders and diabetes and developing novel hypoglycemic agents, with its key advantage lying in nicotinamide pathway regulation and NAD+ stabilization
* Some age and service restrictions apply
Understanding these mistakes makes the chart more useful, because you know not just what to do, but what to avoid